KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma [Corrigendum]

Sun Z, Zhou R, Dai J, et al. Int J Gen Med. 2023;16:4849–4862. The authors have advised that the correspondence section on page 4849 is incorrect. The correct correspondence is as follows. Correspondence: Yao Xu, Institute of Biology and Medicine, College of Life Science and Health, Wuhan University of Science and Technology, No. 2 Huangjiahu West Road, Wuhan, Hubei, 430081, People’s Republic of China, Tel +86-027-68897343, Fax +86-027-68893590, Email [email protected]; Tongcun Zhang, College of Biotechnology, Tianjin University of Science and Technology, #29 the 13th Avenue, TEDA, Tianjin, 300457, People’s Republic of China, Email [email protected]. The authors apologize for this error.